October 4, 2023 11:34 AM EDT
Deals
Manufacturing

So­ma­Log­ic, Stan­dard BioTools to merge in­to $1B mul­ti-omics tech provider

Anna Brown

News Reporter

Pro­teomics biotech So­ma­Log­ic and bi­o­log­i­cal re­search equip­ment com­pa­ny Stan­dard BioTools are con­sol­i­dat­ing to be­come a mul­ti-omics re­search tool provider. The all-stock merg­er is es­ti­mat­ed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

Ex-Kite lead­ers step in at Kyver­na as CEO ex­its af­ter land­ing year's sec­ond-biggest IPO

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times